Strategic Planning With Optimize Feasibility Assessments

Clinical trial feasibility should be driven by data, not guesswork—yet many teams still struggle with inaccurate enrollment estimates, reactive site selection, and costly delays. TA Scan’s Trial Feasibility Flex offers a smarter solution. In this video, we showcase how a Phase III non-small cell lung cancer trial was strategically designed using this innovative platform, resulting in more informed decisions and improved trial efficiency. By integrating high-quality trial intelligence, internal performance metrics, and predictive analytics, teams can generate accurate enrollment forecasts and simulate real-world trial conditions. This allows for optimized feasibility assessments that account for key variables like country selection and start-up timelines. Additionally, the platform enables targeted site and investigator identification by evaluating site performance history and competitive trial activity. Discover how Trial Feasibility Flex transforms feasibility planning from reactive to proactive—accelerating timelines and reducing risk.